Linda Peckel

The potential for metabolic etiologies for migraine opens a whole new approach to treatment, particularly the opportunity to intervene much earlier in the process.

More research is needed to identify the best cost-effective measures for migraine management in underserved and vulnerable people who are uninsured or underinsured.

Researchers suggest that patient dissatisfaction because of adverse effects affects quitting seeking treatment for migraines, among other factors.

Researchers find that adults who had headaches as children, cognitive and psychomotor ability are compromised. Metacognitive skills, anxiety, depression, motivation, academic performance, human social interactions, and stress symptoms are common headache triggers that may be controlled and monitored by patients.

Researchers found that radiofrequency ablation is a safe and effective therapeutic modality for treatment of resistant headaches associated with pericranial neuralgias; patients also reported less dizziness and insomnia.

Research study results showed that treatments for multiple sclerosis precipitated headaches and migraines.

Approximately, 26% of participants who were underinsured or uninsured were able to navigate through consultation, diagnosis, and treatment.